Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery

M I Furman1, S E Benoit, M R Barnard

  • 1Cardiovascular Thrombosis Research Center, Department of Medicine, University of Massachusetts Medical Center, Worcester 01655, USA. mark.furman@banyan.ummed.edu

Insights

Patients with stable coronary artery disease (CAD) exhibit heightened platelet reactivity and form more monocyte-platelet aggregates. These findings suggest increased thrombotic potential in individuals with stable CAD.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Immunology

Background:

  • Atherosclerosis involves platelet-dependent thrombosis and leukocyte infiltration.
  • Understanding cellular events in atherosclerosis is crucial for disease management.

Purpose of the Study:

  • To investigate if patients with stable coronary artery disease (CAD) show increased platelet reactivity.
  • To determine if stable CAD patients have a greater tendency to form monocyte-platelet aggregates.

Main Methods:

  • Whole blood flow cytometry was used to analyze blood samples.
  • Blood was collected from 19 patients with stable CAD and 19 healthy controls.
  • Samples were incubated with or without platelet agonists to assess reactivity.

Main Results:

  • Patients with stable CAD had significantly higher levels of circulating degranulated platelets compared to controls.
  • Platelet reactivity to adenosine diphosphate (ADP), ADP/epinephrine, and TRAP was significantly increased in CAD patients.
  • Stable CAD patients demonstrated a higher prevalence of circulating monocyte-platelet aggregates and an enhanced propensity to form them upon stimulation.

Conclusions:

  • Patients with stable coronary artery disease possess circulating activated platelets.
  • Increased platelet reactivity and monocyte-platelet aggregate formation are characteristic of stable CAD.
  • These findings highlight the role of platelet activation and aggregation in the pathophysiology of stable CAD.
Abstract

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...